journal of men's health
Volume 5, Issue 4 , Pages 297-302 , December 2008

Late-onset hypogonadism: the Asian experience

  • Boon Cheok Lee, MD

      Affiliations

    • Department of Surgery, Hospital Universiti Kebangsaan Malaysia, 56000 Kuala Lumpur, Malaysia
    • Corresponding Author InformationCorresponding author.
    • ,
  • Hui Meng Tan, MD, FRCS, FRCPS

      Affiliations

    • Subang Jaya Medical Center, Selangor, Malaysia and Health Research Development Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Received 29 July 2008 ,Accepted 21 October 2008.

References 

  1. Goh HH. Aging in Asia: a cultural, socio-economical and historical perspective. Aging Male. 2005;8(2):90–96
  2. Low W, Tan H. Asian traditional medication for erectile dysfunction. jmhg. 2007;4(3):245W–250W
  3. Li JY, Li XY, Li M, Zhang GK, Ma FL, Liu ZM, et al. Decline of serum levels of free testosterone in aging healthy Chinese men. Aging Male. 2005;8(3/4):203–206
  4. Lin YC, Hwang TI, Chiang HS, Yang CR, Wu HC, Wu TL, et al. Correlations of androgen deficiency with clinical symptoms in Taiwanese males. Int J Impot Res. 2006;18:343–347
  5. Wong SY, Chan DC, Hong A, Woo J. Prevalence and risk factors for androgen deficiency in middle-aged men in Hong Kong. Metabolism. 2006;55:1488–1494
  6. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–769
  7. Schmidt PJ, Berlin KL, Danaceau MA, Neeren A, Haq NA, Roca CA, et al. The effects of pharmacologically induced hypogonadism on mood in men. Arch Gen Psych. 2004;61:997–1004
  8. Tan HM, Ng CJ, Low WY, Khoo EM, Yap PK, Tan WS. The Subang men's health research – a multiethnic community based study. Aging Male. 2007;10(2):111;(Abstract)
  9. Buvat J. Hormones, metabolism, aging and men's health. In:  Porst H,  Buvat J editor. Standard Practice in Sexual Medicine. Oxford: Blackwell Publshing Group; 2006;p. 234
  10. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91(3):843–850
  11. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT. Endogenous sex hormones, and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90(5):2618–2623
  12. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Toumainen TP, Valkonen VP, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27(5):1036–1041
  13. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371(9628):1827–1835
  14. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87:5001–5007
  15. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288–1299
  16. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990;132:895–901
  17. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166:1660–1665
  18. Ahn HS, Park CM, Lee SW. The clinical relevance of sex hormone levels and sexual activity in the ageing male. BJU International. 2002;89:526–530
  19. Hwang TIS, Lo HC, Tsai TF, Chiou HY. Association among hypogonadism, quality of life and erectile dysfunction in middle-aged and aged male in Taiwan. Int J Impot Res. 2007;19:69–75
  20. Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S, et al. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Impot Res. 2005;17:259–263
  21. Tan HM, Ng CJ, Tan WS, Khoo EM, Low WY. Correlates of symptomatic late onset hypogonadism (SLOH) – Asian context. Abstracts of the first Japan-ASEAN Men's Health & Aging Conference. Asian J Androl. 2006;8(4):506
  22. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:1995–2010
  23. Kim YC. Hormonal replacement therapy and aging: Asian practical recommendations on testosterone supplementation. Asian J Androl. 2003;5:339–344
  24. Beutel ME, Schneider H, Weidner W. Symptoms or complaints in the aging male: which questionnaires are available?. Urologe A. 2004;43:1069–1075
  25. Soh J, Ishida Y, Naito Y, Ochiai A, Naya Y, Mizutani Y, et al. Correlations of AMS score, depression score and hormonal levels with the manifestation of partial androgen decline in the aging male (PADAM). Aging Male. 2004;7:83;[abstract]
  26. Tan HM, Khoo EM, Ng CJ, Low WY, Yap PK, Tan WS. The Aging Males’ Symptoms Scale (AMS) – a general screening instrument for aging males’ health problems?. European Urology. 2007;Supplement 6(2):107
  27. Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X, et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15
  28. Tan HM, Low WY, Tong SF, Khoo ED, Geeta A. Aging Males’ Symptoms Scale (AMS): translation and cross cultural adaptation of Bahasa Melayu version. The Aging Male. 2008;11(1):20
  29. Heinemann LA, Moore C, Dinga JC, Stoehr D. Sensitivity as outcome measure of androgen replacement: the AMS score. Health Qual Life Outcomes. 2006;4:23
  30. Iwamoto T Working Group of the Committee for LOH guideline. Guideline for LOH in Japan: a biological marker for LOH diagnosis is serum free testosterone. Aging Male. 2007;10(1):5–6
  31. Li JY, Zhu JC, Dou JT, Bai WJ, Deng SM, Li M, et al. Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study. Aging Male. 2002;5(1):47–51
  32. Park NC, Yan BQ, Chung JM, Lee KM. Oral testosterone undecanoate (Andriol®) supplement therapy improves the quality of life for men with testosterone deficiency. Aging Male. 2003;6:86–93
  33. Edelstein D, Sivanandy M, Shahani S, Basaria S. The latest options and future agent for treating male hypogonadism. Expert Opin Pharmacother. 2007;8(17):2991–3008
  34. Drewes SE, George J, Khan F. Recent findings on natural products with erectile dysfunction activity. Phytochemistry. 2003;62(7):1019–1025
  35. Ong VYC, Tan BKH. Novel phytoandrogens and lipidic augmenters from Eucommia ulmoides. BMC Complement Altern Med. 2007;7(3):1–11
  36. Chen X, Lee TJF. Ginsenisodes-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum. Br J Pharmacol. 1995;15:15–18
  37. Ang HH, Lee KL, Kiyoshi M. Sexual arousal in sexually sluggish old male rats after oral administration of Eurycoma longifolia Jack. J Basic Clin Physiol Pharmacol. 2004;15(3–4):303–309
  38. Ang HH, Ngai TH, Tan TH. Effects of Eurycoma longifolia Jack on sexual qualities in middle aged male rats. Phytomedicine. 2003;10(6–7):590–593
  39. Ang HH, Lee KL, Kiyoshi M. Eurycoma longifolia Jack enhances sexual motivation in middle-aged male mice. J Basic Clin Physiol Pharmacol. 2003;14(3):301–308
  40. Tambi MIM, Othman S, Saad JM. Water-soluble extract of LJ100 (22% bioactive eurypeptides)™ as a potential natural energizer for healthy aging men. I. Global product literature for LJ-100™. Bradenton, FL: HP Ingredients; 2004. Courtesy of Source. Available at: http://www.nutrilearn.com/hp/lj100research.pdf.
  41. Ong VY, Tan BK. Novel phytoandrogens and lipidic augmenters from Eucommia ulmoides. BMC Complement Altern Med. 2007;7:3
  42. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998;159:433–436

PII: S1875-6867(08)00212-1

doi: 10.1016/j.jomh.2008.10.006

journal of men's health
Volume 5, Issue 4 , Pages 297-302 , December 2008

Article Tools